Clinical Trial Update: Avidination for RadionuclideTHerapy in Nonpalpable Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial of Avidination for Radionuclide Therapy in nonpalpable breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avidination for Radionuclide Therapy

Snippet

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Conditions: Breast Cancer | Phase 1 | Status: TERMINATED